Send feedback

BMPR2 p.Arg303His

c.908G>A · rs200948870 · VCV425842

Likely pathogenic Expert panel
Classification
Likely pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.1054 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0165%, mid)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
pulmonary arterial hypertension

ClinGen expert panel — Pulmonary Hypertension VCEP

Likely Pathogenic for pulmonary arterial hypertension. Applied ACMG criteria (verbatim):

PS3 PM1

Curation rationale (ClinGen, verbatim)

The BMPR2 c.908G>A variant is a missense variant in exon 7 predicted to result in substitution of arginine to histidine at amino acid position 303 (p. Arg303His). The highest population minor allele frequency in gnomAD v2.1.1 (controls) is 0.00043 (1/2334 alleles) in subpopulation “remaining individuals” which exceeds the ClinGen PH VCEP threshold (<0.01%) for PM2 (PM2 not met). Neither BS1 (≥0.1%) nor BA1 (1%) met. The computational predictor REVEL gives a score of 0.497 indicating neither PP3 (≥0.75) nor BP4 (≤0.25) met. SpliceAI algorithm predicts no deleterious effect on acceptor or donor splice site. The variant is located in the kinase domain (PM1 met). Genetic evidence showed the presence of the variant in only one IPAH patient (PMID:16429395) (PS4 not met). Immunofluorescence staining of Hela cells transfected with an R303H mutant construct showed mislocalization of BMPR2 protein to the endoplasmic reticulum (PMID:25688877) and included positive and negative controls (PS3 met). In summary, the variant meets the criteria to be classified as likely pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PS3, PM1 (VCEP specification version 1.1, 1/18/2024).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.1054likely benign ⚠ discordant with ClinVar
REVEL0.497indeterminate
SaProtLLR -9.39tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.4, phastCons 1
Regional constrainto/e 0.78unconstrained · MANE · 153 kb · p 2.6e-06 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0165% Middle Eastern · 1/6,058 alleles
Filtering AF 0.00514% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00376%
Overall 0.00409% 66/1,612,518 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0165% 6,058
South Asian 0.00989% 10,116
Admixed American 0.00837% 11,954
African / African-American 0.00671% 14,900
European (non-Finnish) 0.00364% 27,438
Remaining individualsnot grpmax-eligible 0.0032% 31,241
East Asian 0.00223% 44,818

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BMPR2
Protein
p.Arg303His
Coding
c.908G>A
MANE Select
NM_001204
dbSNP
rs200948870
Type
single nucleotide variant
Location
chr2:202520142 (GRCh38)
Gene constraint
LOEUF 0.376 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 58.07 · 7 PDB
Residue 303
a UniProt-annotated variant site (in pph1; changed localization to the plasma membrane); the protein kinase domain; a UniProt-annotated variant site (in pph1; loss of localization to the plasma membrane; localized to the cytoplasm); an α-helix
Full BMPR2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

pulmonary arterial hypertension — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: pulmonary venoocclusive disease 1pulmonary hypertension, primary, 1

For Idiopathic/heritable pulmonary arterial hypertension (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (United States)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bmpr2-p-arg303his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown